Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$21.15 - $27.96 $4,230 - $5,592
200 New
200 $5,000
Q1 2023

May 01, 2023

SELL
$10.12 - $14.91 $49,810 - $73,387
-4,922 Reduced 48.73%
5,178 $58,000
Q4 2022

Feb 07, 2023

BUY
$8.75 - $14.02 $83,125 - $133,190
9,500 Added 1583.33%
10,100 $139,000
Q2 2022

Aug 04, 2022

SELL
$15.06 - $30.65 $518,064 - $1.05 Million
-34,400 Reduced 98.29%
600 $9,000
Q1 2022

Apr 14, 2022

BUY
$23.26 - $42.41 $814,100 - $1.48 Million
35,000 New
35,000 $1.02 Million
Q4 2021

Jan 18, 2022

SELL
$37.54 - $57.51 $7,508 - $11,502
-200 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$45.91 - $59.67 $59,682 - $77,571
-1,300 Reduced 86.67%
200 $9,000
Q2 2021

Jul 19, 2021

BUY
$43.3 - $67.17 $64,949 - $100,755
1,500 New
1,500 $87,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $426M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.